News

Under terms of the agreement, Konica Minolta Opto (KMOT) will have a defined period of time to evaluate certain applications of Guided Therapeutics’s (GT’s) technology, including the potential

The financing will fund the company through 2010. It will be used to advance Apoptos’s portfolio of small molecule drugs that are directed at inducing tumor cell apoptosis,

The company does not anticipate any disruption in its service to customers as these changes occur. Affected employees, who are located throughout the US, will be notified by

The European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have formed a strategic partnership to promote innovative research projects and help accelerate the discovery

According to the Association of the British Pharmaceutical Industry (ABPI), the government’s move is likely to have potential repercussions in the pharma sector with many pharma companies considering

The survey found that 35% of the companies polled expected to cut their investment in R&D over the next 12 months, while 46% plan to conduct fewer clinical

In this new collaboration, BioFocus DPI will provide assay development and high-throughput screening services for several Allergan targets. Furthermore, BioFocus DPI’s computational chemists plan to work together with

The supplemental new drug application (sNDA) is based on seven Phase III, placebo-controlled studies that assessed the efficacy and safety of once-daily treatment with Seroquel XR in patients

The combined offering bundles the DiscoveRx’s cellular assays, such as PathHunter ß Arrestin and cAMP Hunter with LabChip systems to help pharmaceutical and biotechnology researchers more efficiently discover